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Abstract: 
 Ghrelin is a peptide hormone involved in hunger signaling and other 
physiological processes.  To become active, ghrelin first must be acylated by 
ghrelin O-acyltransferase (GOAT). This enzyme carries out a post-translational 
modification that attaches an octanoyl group to the side chain of the serine 3 (S3) 
residue of ghrelin.  With ghrelin linked to hunger signaling, memory, and other 
physiological processes, GOAT has been identified as a potential drug target.  
However, inhibitor design is difficult because not much is known regarding the 
active site structure and catalytic mechanism of GOAT.  This study reports the 
design of a novel fluorescence-based assay that allows the use of ghrelin substrate 
mimics and derivatives to interrogate ghrelin recognition by GOAT. The results 
of this research can directly contribute to helping in the development of novel 
GOAT inhibitors. 
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Figure 1: Acylation of the ghrelin hormone by GOAT. 
I. Introduction: 
 Ghrelin is a secreted peptide hormone initially discovered in 1999.
1,2
 
While first found to stimulate appetite, it has since been proposed to play a role in 
other functions such as uterine signaling, memory, and glucose metabolism.
2-5
 In 
order to become biologically active, ghrelin must undergo a series of maturation 
steps after expression. One of these steps is acylation of the ghrelin precursor 
proghrelin (which shall be referred to only as ghrelin from this point forward) by 
the enzyme ghrelin O-acyltransferase (GOAT).  This acylation results in addition 
of an octanoyl group to the side 
chain hydroxyl of serine 3 (S3) of 
ghrelin (Figure 1).  This 
octanoylation is required for 
ghrelin to bind and activate the 
growth hormone secretatogue 
receptor GHSR-1a.
2
 
 GOAT was first identified in 2008 as an integral membrane protein 
member of the MBOAT (membrane-bound O-acyltransferase) enzyme family.
6,7
  
However, the structure, active site, and catalytic mechanism of GOAT remain 
largely undefined, due to the difficulty of purifying properly folded GOAT from 
the cell membrane. Hydropathy plots suggest that GOAT has 7 or 8 
transmembrane helicies, and two conserved residues (Asn307 and His338) have 
been shown to be important for enzyme activity, with alanine mutations at these 
positions resulting in a loss of enzyme activity.
6,8 
 Regarding GOAT substrate 
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recognition, previous work has shown that the G1 and F4 residues of ghrelin are 
involved in recognition by GOAT and subsequent catalysis.
8
   
With these previous results and limitations in mind, the purpose of my 
research in the Hougland lab during my tenure at Syracuse University has been 
dedicated to the development of tools for studying GOAT activity and substrate 
selectivity.  This research is significant because it opens the doors for the rational 
design of GOAT inhibitors by determining the interactions that occur on the 
molecular level between the active site of GOAT and its substrate, of which the 
only known is ghrelin.  Such inhibitors could be made for the purpose of 
becoming drugs that combat obesity through the prevention of hunger signaling, 
as well as diseases that could be affiliated with ghrelin’s other biological roles 
such as Prader-Willi Syndrome and diabetes.   
Towards these goals, I have pursued two complementary projects.  The 
first project was construction of several affinity-tagged versions of the human 
isoform of GOAT (hGOAT) to allow for expression and purification in Sf9 insect 
cells.  My second project involved the development of a fluorescence-based assay 
for hGOAT activity.  This assay utilizes a fluorescently labeled peptide substrate 
that permits structure-reactivity analysis of hGOAT activity.  Changes in substrate 
reactivity with hGOAT upon substrate mutation or chemical modification can 
reveal interactions within the GOAT active site involved in ghrelin recognition 
and octanoylation. 
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Figure 2: Anti-His antibody Western Blot showing cross-
reactivity. A TEV Protease-His6 positive control (lane 1), 
pFastBacDual/GusCat negative control (lane 8), and Sf9 
membrane fractions (lane 9) all react with the anti-His 
antibody. The molecular weight of GOAT is 55kDa (circled in 
sample). 
II. hGOAT/tag Gene Construction- Overview 
In the Hougland lab, 
hGOAT is expressed in Sf9 
insect cells from an hGOAT 
DNA construct containing a 
C-terminal His10-tag, using a 
previously reported 
protocol.
8
 However, 
confirmation of hGOAT 
expression using Western 
blotting against the C-
terminal His tag has been difficult due to cross-reactivity between the anti-His 
antibody and endogenous proteins in the GOAT-containing membrane fractions 
and negative control fractions (Figure 2).  The negative control in lane 8 is protein 
expressed from the pFastBacDual/GusCat plasmid which contains no GOAT-
His10 gene, while lane 1 contains TEV Protease with a His6 tag.  
To resolve this issue, I have constructed new hGOAT constructs wherein 
the His-tag is replaced with one of three affinity tags: FLAG (amino acid 
sequence DYKDDDK), HA (YPYDVPDYA), and Myc (EQKLISEEDL).  These 
constructs may allow for more facile confirmation of hGOAT expression by 
Western blot.  The new hGOAT constructs may also allow for the purification of 
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Figure 3: pUC57/MBOAT4i-His vector. The restriction 
sites used in my work are EcoRI ( 396), XhoI (1750), and 
XbaI (1792). 
the GOAT enzyme using affinity columns, which has proved unsuccessful with 
the current His10 tag. 
II. hGOAT/tag Gene Construction - Results and Discussion 
Sf9 Expression: C-terminal tag replacement 
 The final desired pFastBacDual/MBOAT4-X vector (where X is either the 
Myc, FLAG, or HA tag) was constructed through a series of restriction enzyme 
digests and ligations.  The pUC57/MBOAT4-His10 and pFastBacDual/MBOAT4-
His10 vectors used in the lab containthree important restriction enzyme sites 
regarding this cloning project: an EcoRI site at the beginning of the MBOAT4 
gene, a XhoI site in the linker region between the MBOAT4 gene and His10 
sequence, and a XbaI site 
immediately after the His10 
sequence (Figure 3).  
First, the His10 tag 
attached to the 3’-end of 
theMBOAT4 gene in 
pUC57must be replaced with 
DNA coding for either the myc, 
FLAG, or HA tag.  This DNA 
sequence inserts for these tags 
was formed by annealing two 
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complementary oligonucleotide primers to generate the DNA sequence for the 
desired affinity tag with XhoI and XbaI restriction site overhangs at the 5’ and 3’ 
ends.  After successful ligation of the new affinity tag sequence, the MBOAT4-X 
gene is excised from the pUC57 vector and ligated into the pFastBacDual vector 
using the EcoRI and XbaI restriction sites.  The pFastBacDual (pFBD) vector 
allows for the recombination of the MBOAT4-X gene into the baculoviral 
genome present in the baculovirus shuttle vector (bacmid) within DH10Bac strain 
of E. coli. This bacmid is then transfected into the Sf9 insect cells, leading to 
baculovirus production and hGOAT expression.  
At each of the ligation steps described above, the resulting plasmid was 
analyzed via gel electrophoresis and gene sequencing (Genscript) to confirm 
successful ligation.  To analyze a ligation to determine success, a single restriction 
enzyme digest is run in addition to a double restriction digest.  The single digest 
linearizes the entire (plasmid)/MBOAT4-X gene, which removes plasmid 
supercoiling to allow accurate determination of plasmid size/length on an agarose 
gel.  The double digest excises the gene completely, allowing for the observation 
and size determination of the ligated insert and parent vector.   
The gels in Figure 4 show the confirmation of the 
pFastBacDual/MBOAT4-X ligations, the last step in creating the recombinant 
hGOAT gene with FLAG, Myc, and HA tags. Figure 4a is an agarose gel for 
analysis of EcoRI and XbaI double digests of multiple preparations of 
pFastBacDual/MBOAT4-FLAG plasmids (lanes 5, 6, and 7). Following EcoRI – 
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XbaI double digestion of the pFastBacDual/MBOAT4-FLAG vector, two bands 
are observed upon analysis by agarose gel electrophoresis, approximately 5000- 
 
 
 
5500bp and 1400bp, corresponding to parent pFBD vector and MBOAT4-FLAG 
insert respectively.  Following confirmation of ligation by gel electrophoresis, 
successful construction of the pFBD/MBOAT4-FLAG plasmid was confirmed by 
DNA sequencing.  
Ligations of the pFastBacDual/MBOAT4-Myc and 
pFastBacDual/MBOAT4-HA plasmids were similarly analyzed by agarose gel 
electrophoresis (Figure 4b;   Myc (lanes 2-7), HA (lanes 8-13)). Following EcoRI 
– XbaI double digestion, pFBD/MBOAT4-Myc plasmid ligation was confirmed 
for the plasmid samples in lanes 3 and 5, based on the cut DNA running at the 
appropriate band size. Lane 7 DNA is a failed EcoRI/XbaI double digest, 
       Lanes:       1    2    3    4    5    6    7    8 1   2    3   4    5    6   7   8    9   10 11 12  13  14 
~5000 bp 
1400 bp 
~5000 
bp 
1400 
bp 
Figure 4: Gel analysis of digests confirming the presence of pFBD/MBOAT4-X.  
Left: EcoRI and XbaI double digests of pFBD/MBOAT4i-FLAG plasmids (5, 6, 7) and pFBD/MBOAT4-Myc/HA 
plasmids (lanes 2,4, 8). 2-log DNA ladder is run in lane 1. 
Right: EcoRI and XbaI single and double digests of pFBD/MBOAT4i- Myc (lanes 2-5) and HA (lanes 10-13). 2-
log DNA ladder is run in lanes 1, 14. Lanes 6-9 were failed pFBD/MBOAT4-Myc/HA digests. 
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suggesting a failed ligation.  These results were confirmed later by DNA 
sequencing. 
Identical digest and analysis is applied to lanes 9, 11, and 13, which 
contain preps of separate pFastBacDual/MBOAT4-HA ligation products.  Lanes 
11 and 13 show bands at the appropriate 5000-5500bp range and 1400bp, 
indicating successful ligation. Multiple bands are shown in lane 9, characteristic 
of uncut DNA and a failed ligation. DNA sequencing confirmed the successful 
construction of the MBOAT4-HA sequence for the plasmids in lanes 11 and 13.   
To confirm the size of the ligated plasmids, the pFBD/MBOAT4-Myc 
(lanes 2, 4, 6 in Figure 4b) and pFBD/MBOAT4-HA (lanes 8, 10, 12 in Figure 
4b) plasmids were digested with EcoRI alone to yield linearized plasmid 
(pFBD/MBOAT4-Myc, lanes 3, 5, 7; pFBD/MBOAT4-HA, lanes 9, 11, and 13).  
These single digests confirm the presence of the MBOAT4i-X insert in the 
pFastBacDual vector by the linearized plasmids exhibiting a shift of +1400bp 
relative to the pFastBacDual parent vector. The single digests also indicate a 
failure of ligation for several plasmids (lanes 6/7 and 8/9). 
In conclusion, I have synthesized hGOAT expression constructs with C-
terminal FLAG, Myc, and HA affinity tags. These constructs are currently being 
investigated as options for expression and purification of hGOAT.  
III. GOAT Assay Design and Utilization- Overview 
The main focus of my Capstone research has been the development and 
employment of a novel fluorescence-based assay to analyze the substrate 
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Figure 5: Mass spectra of GSSFLC-AcDan (M+Na)
+
 
= 859.84. Na
+
 adducts are frequently observed 
during mass spectrometry of substrates. 
specificity of GOAT.  This assay involves the attachment of acrylodan, a small 
fluorophore, to the cysteine residue on a short synthetic peptide that will serve as 
a ghrelin substrate mimic.  The resulting fluorescent peptide is incubated with 
recombinantly-expressed hGOAT, leading to peptide octanoylation.  The extent 
of peptide acylation is then determined using reverse-phase HPLC to separate the 
substrate and octanoylated product.  Octanoylation of the product peptide is also 
confirmed using mass spectrometry. The development of this fluorescent substrate 
was recently published in Analytical Biochemistry.
9
 
The use of acrylodan also provides the opportunity for development of a 
continuous assay for hGOAT-catalyzed acylation.  Acrylodan is an 
environmentally sensitive fluorophore whose  fluorescence increases in response 
to changes in the polarity/hydrophobicity of its local environment.
10
  When 
GOAT acylates the peptide 
conjugated to acrylodan, the 
octanoyl group added  to the side 
chain of serine 3 will increase 
local hydrophobicity.  This 
reduction in local polarity will 
lead to an increase in acrylodan 
fluorescence, thereby providing a 
signal that reflects the extent of 
ghrelin peptide acylation.   
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Figure 6: hGOAT octanoylation analysis. GOAT 
assays using the (-) membrane fractions (A) lacks 
the peak at 12.5min present in the (+) fraction 
assay (B).  This peak was isolated and analyzed 
via mass spectrometry (C), which shows the 
octanoylated peptide with Na
+
 and K
+
 adducts. 
III. GOAT Assay Design and Utilization- Results and Discussion 
Fluorescent hGOAT substrate Development 
 For substrate development, we used the N-terminal sequence of ghrelin 
(GSSFLS) as a template, and incorporated cysteine residues at several positions to 
allow for acrylodan attachment. Short peptides mimicking the N-terminal 
sequence of ghrelin have been shown to serve as GOAT substrates.
8
 One of first 
substrates is the 6-mer GSSFLC-AcDan. The 
formation of the substrate upon acrylodan 
labeling of the GSSFLC peptide was 
confirmed by mass spectrometry (Figure 5).  
GOAT Octanoylation of GSSFLC-AcDan  
GSSFLC-AcDan was tested as a 
substrate for expressed GOAT by incubation 
in the presence of membranes that expressed 
GOAT as described in Experimental Details; 
membranes from Sf9 cells expressing β-
glucuronidase serve as a negative control.  As 
seen in Figure 6, incubation with the (-) 
membrane fractions did not alter the 
GSSFLC-AcDan peptide.  However, 
incubation with hGOAT-containing 
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Figure 7: Acetylation of GSSFLC-AcDan 
and SSFLC-AcDan inhibit GOAT acylation. 
These results cumulatively suggest the 
importance of the free N-terminal amine 
and lack of an α-sidechain as key 
recognition factors for GOAT. 
membranes produces a new peak with a longer retention time.  This shift in 
retention time in reverse-phase HPLC is consistent with the increase in substrate 
peptide hydrophobicity upon octanoylation.  Mass spectrometry of the new peak 
with longer retention time confirmed it to be octanoylated GSSFLC-AcDan.  
Inhibition with Metal Chelators 
 In addition to being inhibited by octanoyl-[Dap3]-ghrelin, a known GOAT 
inhibitor, GOAT is also inhibited by the addition of metal chelators to the 
reaction.  Assays have been performed with EGTA (ethylene glycol tetraacetic 
acid) and 1,10-phenanthroline.  EGTA was found to partially inhibit GOAT 
activity, while 1,10-phenanthroline efficiently and completely inhibits GOAT 
activity.  These data suggest that a metal ion 
may be required for GOAT- catalyzed 
ghrelin acylation. 
Structure-activity Studies of ghrelin 
recognition by hGOAT  
 Following the development of our 
fluorescent peptide substrate for hGOAT, 
this substrate was used to investigate 
hGOAT recognition of ghrelin focusing on 
interactions with the glycine 1 (G1) and 
serine 2 (S2) residues of the GSSFL- 
sequence.  In these assays, a reaction with 
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Figure 8: Mutating the S2 residue results in levels of 
activity that vary with steric interactions and the 
presence of a hydroxyl on the X2 sidechain. 
unmodified GSSFLC-AcDan was always run in parallel to control for changes in 
enzyme activity, substrate degradation, and other potential factors.  
Previous studies of mouse GOAT have indicated that the N-terminal 
glycine of ghrelin is necessary for GOAT activity.
8
 To identify the specific 
interactions involved in recognition of this glycine, three potential recognition 
elements of this glycine residue were analyzed: the N-terminal amine, the 
carbonyl, and the lack of steric bulk on the side chain.  These recognition 
elements were separately tested by assaying GOAT activity with two acetylated 
substrates, [Ac]GSSFLC-AcDan and [Ac]SSFLC-AcDan.  The former removes 
the N-terminal amine by forming an amide and adds steric bulk, while the latter 
only removes the N-terminal amine.  To test the effect of steric bulk at this 
position, substrates SSSFLC-AcDan and ASSFLC-AcDan were also analyzed, 
which add methyl or hydroxymethyl side chains at the alpha carbon as compared 
to glycine.  As shown in Figure 7, a severe loss of activity was observed with all 
modifications, resulting in either 
no activity or extremely low 
activity in the case of 
[Ac]GSSFLC-AcDan.  This 
indicates that the N-terminal 
amine, in addition to a lack of 
steric bulk on the first amino acid, is 
important for substrate recognition by 
hGOAT. 
12 
 
Figure 9: A schematic model of the GOAT-substrate complex can be established based on the findings of 
this research. The knowledge of these interactions can help in the design of specific novel inhibitors of 
GOAT to treat disease.
5 
 GOAT recognition at the S2 residue was tested by mutating this serine to 
an alanine, threonine, valine, phenylalanine, and tryptophan.  Alanine removes the 
polar hydroxyl group while slightly decreasing steric bulk, threonine maintains 
the polar hydroxyl while increasing sterics, and valine removes the hydroxyl 
while increasing sterics.  Greater steric changes were also tested through 
phenylalanine and tryptophan.  The results of these experiments are shown in 
Figure 8, which indicates that the presence of a hydroxyl group at the second 
position of the GSSFL- sequence is important for GOAT recognition.  Activity 
also decreases with increasing side chain size, suggesting the possibility of steric 
crowding the serine 2 binding pocket.  The loss of activity upon increase in steric 
bulk at serine 2 is consistent with the lack of activity observed for a substrate with 
acrylodan at this position (GC(AcDan)SFLS).  
 These results, in addition to data from previous studies reporting the 
importance of the F4 residue,
 
allow for us to begin to construct a basic model of  
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the interactions that occur between the GOAT active site and GOAT substrates, as 
shown in Figure 9.
8,11,12
 The N-terminal glycine is recognized based on at least 
two properties/groups: the free amine at the N-terminus, and the lack of steric 
bulk at the alpha carbon.  At the second amino acid position, the presence of a 
hydroxyl group is aids in ghrelin recognition and modification by hGOAT. There 
is also a steric constraint at the S2 position, but that this constraint is less severe 
than at the N-terminal glycine. 
IV. Experimental Details 
Sf9 Expression: Annealing of FLAG, Myc, HA oligonucleotides for ligation 
The sense and antisense oligonucleotides for each tag gene insert (Myc, 
HA, FLAG) were annealed in 10μL total volume, with the forward (sense) and 
reverse (antisense) oligonucleotides (50 pmol in 1μL each) added to ultra pure 
water (8μL). Each mixture was mixed by vortex, spun down, and annealed using a 
BioRad MyCycler thermocycler with the following program: 94˚C, 5 min; two 
cycles of 94˚C, 30s; 80˚C, 5 minutes; 72˚C, 7 min; 66˚C, 7 min; 60˚C, 3 min; 
52˚C, 3 min; 46˚C, 3 min; 37˚C , 20 min; final hold at 4˚C. This process anneals 
the corresponding primers together to form the DNA sequence for the desired 
affinity tag with XhoI and XbaI cut sticky ends on the 5’ and 3’ ends of the 
annealed duplex.  These annealed products can then be ligated directly into the cut 
pUC57/MBOAT4i vector, and are frozen at -20°C until needed. 
Restriction Enzyme Digestion 
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 20L digests are set up by combining 10X New England Biolabs Buffer 4 
(2L), 10X Bovine Serum Albumin (2L), DNA (500-1500ng), and the 
appropriate restriction enzymes (1L, 20 units), then voluming up to 20L with 
ultrapure water.  To cut out MBOAT4-X EcoRI and XbaI are used, while XhoI 
and XbaI are use to only cut out the X-tag.  The range in amount of DNA and 
restriction enzyme is due to the purpose of the digest: if only for analytical 
purposes 500ng is used, but if DNA will be extracted and used in a ligation more 
is digested.  All digests are run for 2h at 37C, followed by analysis and 
purification of the vector digestion by agarose gel electrophoresis (0.8% agarose, 
1X TAE buffer); the size of the inserts and linearized vector were verified by 
comparison to a DNA standards ladder. Double digested DNA was purified using 
the EZ-10 Column PCR Purification Kit (Bio Basic Inc.) per the manufacturer’s 
instructions. 
DNA Ligation and DH5 Transformation 
 Ligations were performed using a 1:3 molar ratio of vector to insert. 
Ligation reactions were performed under the following conditions:  for 
pUC57/MBOAT4 and the X-tag (20μL total volume), XhoI-XbaI double digested 
pUC57/MBOAT4 (50ng), annealed X-tag oligomer reaction (50pmol), 2x Quick 
Ligase buffer (10μL), T4 Quick Ligase (New England Biolabs, 1μL), and ultra 
pure H2O; for pFBD and MBOAT4-X (20 μL total volume), EcoRI-XbaI double 
digested pFBD (50ng), EcoRI-XbaI double digested MBOAT4-X (50ng), 2x 
Quick Ligase buffer (10 μL), T4 Quick Ligase (New England Biolabs, 1 μL), and 
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ultra pure H2O.  Following addition of Quick Ligase, reactions were incubated at 
room temperature for 5 minutes.  Ligation mixtures (4L) were then transformed 
into a 50 L aliquot of chemically competent Z-competent DH5 cells (Zymo 
Research) followed by incubation on ice for 10 minutes. Transformed bacteria 
were spread on LB-ampicillin plates (100g/mL) and incubated at 37 C 
overnight.  
 Following overnight incubation at 37 
o
C, single colonies were inoculated 
into LB media (5 mL) containing ampicillin (100g/mL) in sterile culture tubes. 
These cultures were incubated overnight at 37 C with shaking (225 RPM). 
Following overnight growth, plasmids were purified from the saturated cultures 
using EZ-10 Spin Column Plasmid DNA kit (Bio Basic Inc.) per manufacturer’s 
instructions.  Inserts were verified by double digestion with EcoRI and XbaI to 
excise the ligated insert followed by agarose gel electrophoresis and DNA 
sequencing (Genscript).  
Transformation into DH10Bac Cells, Blue-White Screening 
To generate bacmid for transfecting into Sf9 insect cells, pFastBacDual 
vectors were transformed into DH10Bac E. coli cells by adding chilled plasmid 
(400ng) to an aliquot of Z-competent DH10Bac cells (100μL), followed by 
incubation on ice for 5 minutes. The transformed bacteria were then spread onto 
LB agar plates containing kanamycin (50μg/mL), tetracycline (10μg/mL), 
gentamicin (7μg/mL), IPTG (40μg/mL), and XGal (100μg/mL). Plates were 
incubated at 37 C for 48 hours, at which point bacteria with successful bacmid 
16 
 
Figure 10: X-gal cleavage leads to chromophore production. (1) is an indole derivative, with (2) being a 
dimerized product between two cleaved indole molecules. (2) is the chromophore that produces the blue 
coloration. 
recombination were identified by blue/white screening. White colonies were re-
streaked onto LB agar plates containing kanamycin, tetracycline, gentamicin, 
IPTG, and XGal and incubated for 48 hours at 37 C to verify bacmid 
recombination by blue/white screening.  
The presence of X-gal in the plate media enables determination of 
successful transformation by blue-white screening, where colonies possessing the 
recombinant DNA are clear while those without are blue.  This difference is due 
to a gene in DH10Bac bacmid genome that codes for β-galactosidase, of which X-
gal is a substrate.  If transformation is successful, the MBOAT4i-X gene is 
inserted in the middle of the gene coding for β-galactosidase, preventing synthesis 
of the enzyme and keeping all X-gal in the colony intact.  If transformation is 
unsuccessful, β-galactosidase will cleave X-gal, forming a blue chromophore as a 
side-product (Figure 10).  This allows one to easily distinguish and select for 
transformed plasmid. 
Clear colonies are picked and re-streaked on identical plates and grown up 
for another 2 days, to ensure there are 
17 
 
Figure 11: Substrate formation. The α,β-unsaturated ketone of 
acrylodan reacts with the free thiol on the ghrelin mimic 
GSSFLC.  At pH = 7.8 this thiol is close to 50% deprotonated, 
helping to push the reaction further. 
no non-recombinant bacmid colonies. The clear colonies from these plates are 
picked and grown up in, then their recombinant bacmid is purified using a 
Macherey-Nagel Nucleobond Bac100 Kit.  This purified DNA is then ready to be 
transfected into Sf9 insect cells for expression. 
GOAT Assay Fluorescent Substrate Development 
 To synthesize the acrylodan-labeled substrate, the short synthetic peptide 
and acrylodan are combined in 1mL of 1:1 50mM N-(2-hydroxyethyl)piperazine-
N’-(20hydroxypropanesulfonic acid) buffer (pH 7.8)/acetonitrile, with final 
concentrations being 50μM peptide and 500μM acrylodan.  This reaction mixture 
is allowed to incubate overnight at room temperature covered in aluminum foil to 
prevent photobleaching of the acrylodan.  During this process, the acrylodan 
conjugates to the free thiol of a singular cysteine residue on the peptide through 
the Michael Addition 
reaction, as shown in 
Figure 11. 
Acrylodan-
labeled peptides are 
then purified by 
reverse phase HPLC 
on a 9.4mm x 250mm 
column using a mobile 
phase of water containing 
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0.05% trifluoroacetic acid (TFA) (65%) and acetonitrile (35%) flowing at 
4.2 ml/min over 21 min. Labeled peptides eluting at approximately 6 to 10 min 
are easily detected by UV absorbance at 360nm and fluorescence at 485nm.  As 
well, fractions of the initial peptide-acrylodan labeling reactions were analyzed by 
MALDI–TOF mass spectrometry to verify the presence of the product at the 
appropriate retention time.  This was done using a matrix of saturated sinapinic 
acid in 0.1% TFA and 50mM ammonium phosphate, mixed in a 1:1 volume with 
the fraction sample. 
GOAT Activity, Inhibition, Substrate Selectivity 
The assay for GOAT activity is carried out by combining octanoyl-CoA, 
the fluorescent peptide substrate of choice, palmitoyl-CoA, and membrane 
fractions of Sf9 cells that have expressed GOAT and allowing the enzyme to 
carry out the acylation reaction using octanoyl-CoA.  During inhibition 
experiments, the desired inhibitor is also added, with the fluorescent substrate 
always being GSSFLC-acrylodan, the sequence that mimics natural ghrelin. 
Membrane fractions from Sf9 cells expressing hGOAT are thawed on ice 
and passed through an 18-gauge needle 10 times. Membranes are then centrifuged 
(1000g, 1 min), with the supernatant collected and added to hGOAT reactions. 
Assays are performed with 50μg of membrane protein, 1.5μM labeled peptide 
substrate, 500μM octanoyl-CoA, 100μM palmitoyl-CoA, and 50mM HEPES (pH 
7.0) in a total volume of 50μl, with the substrate being added last to initiate the 
acylation reaction. Assays comparing the reactivity of different peptide substrates 
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were performed in parallel using the same stock of membrane protein and other 
reaction components, with peptide substrates added last.  All assays are incubated 
at room temperature and stopped by the addition of 50μl of 20% acetic 
acid/isopropanol to halt enzymatic activity.  Addition of the stop solution prior to 
substrate addition resulted in no activity. 
 Assays are analyzed by reverse phase HPLC with a 4.6 × 150mm column, 
using a gradient from 30% acetonitrile in water containing 0.05% TFA to 63% 
acetonitrile in water containing 0.05% TFA flowing at 1 ml/min over 14 min, 
followed by 100% acetonitrile for 5 min. Acrylodanylated peptides were detected 
by UV absorbance at 360 nm and fluorescence (λex = 360 nm, λem = 485 nm). 
Peptide substrates typically elute with a retention time of 5 to 7 min 
(approximately 42–46% acetonitrile), with the octanoylated peptide product 
eluting at approximately 12 min (∼58% acetonitrile).  MALDI-TOF mass 
spectrometry was also used to initially determine presence of the acylated 
substrate in the 12min fraction, with matrix conditions identical to those used in 
the peptide labeling reaction analysis. 
To determine the percent conversion of the acylation reaction, peaks on 
the HPLC Fluorescence Chromatogram corresponding to unacylated peptide 
substrate and acylated peptide substrate are integrated using Chemstation for LC 
(Agilent Technologies).  The percent of total substrate reacted is determined by 
dividing the area of the emission peak at 485nm of the 12min peak by the total 
area of the 5-7min peak and the 12min peak, as shown below: 
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Fluorescence is used instead of UV absorbance due to the lower detection limit of 
the lab fluorometer compared to the lab UV spectrophotometer.  For reactions 
involving GOAT inhibitors, the degree of enzyme activity when comparing 
GOAT with inhibitor to GOAT without inhibitor is calculated as follows: 
            
                          
                             
 
V. Conclusion: 
I have worked toward developing the tools that will aid future researchers 
in the Hougland Lab in determining the structure and catalytic mechanism of the 
GOAT active site.  The fluorescence-based assay I have developed along with my 
colleagues allows for structure-activity studies of hGOAT-catalyzed ghrelin 
acylation to investigate GOAT substrate specificity and catalytic mechanism.  Our 
assay also provides the capability for rapid screening of potential hGOAT 
inhibitors.  These tools developed in my research will aid in hGOAT inhibitor 
design, with these inhibitors potentially serving as therapeutics for diseases such 
as obesity, Prader-Willi Syndrome and diabetes. 
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Capstone Summary 
After the human genome was sequenced in 2003, it was revealed that 
human DNA only coded for approximately 30,000 genes.  This was surprising to 
many in the scientific community, as the human proteome was predicted to 
contain 10- to 100-fold higher diversity than that predicted within the genome. 
One potential explanation for the difference between the number of genes and the 
number of chemically distinct protein forms encountered in humans (and other 
complex organisms) is posttranslational modification (PTM).   
PTMs are chemical modifications to proteins after they are synthesized by 
the ribosome.  These modifications can introduce new functionality and alter 
protein structure, leading to new reactivity.  Post-translational modifications play 
a central role in biology and have been linked to human diseases like cancer, 
cardiovascular disease, and obesity.  In Dr. Hougland’s lab, my research focuses 
on developing a better understanding of the enzymes (proteins that perform 
biological reactions) that carry out these modifications.  My project focuses on 
acylation of the hormone ghrelin by the enzyme ghrelin O-acyltransferase 
(GOAT).   
Ghrelin is a small protein hormone that stimulates hunger.  One key step 
in activating ghrelin is its acylation by GOAT, a reaction where the enzyme reacts 
with a fatty acid group (called octanoyl-CoA) and attaches it onto the hormone.
 
 
This PTM allows the now-activated ghrelin molecule to bind to its receptor, 
GHSR-1a, and activate hunger signaling.
2
 There is also evidence suggesting 
ghrelin is involved in regulating glucose metabolism, uterine cell signaling, and 
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memory.
3-5  
With this wide range of potential roles for ghrelin in biology, our 
studies of ghrelin acylation by GOAT have the potential to impact multiple 
research areas and diseases through aiding in the development of drugs that stop 
GOAT activity.  Drugs that block GOAT-catalyzed ghrelin acylation could be 
used as potential anti-obesity treatments. Inhibiting ghrelin acylation could also 
be involved in treating other diseases affiliated with ghrelin such as diabetes and 
Prader-Willi Syndrome. 
The enzyme that catalyzes ghrelin octanoylation, ghrelin O-acyltransferase 
(GOAT), was discovered in 2008.
6,7
 GOAT is an integral membrane protein, with 
the folded protein associating with cell membranes.  Studying integral membrane 
proteins introduces many complications in enzyme expression and 
characterization, as it is very difficult to purify these types of proteins from the 
cell membrane.  Because of this, not much is known about the structure of GOAT 
or its chemical mechanism of acylation.  
For the past two years, my research in the Hougland lab has focused on 
developing tools that can be used in the basic characterization of GOAT-catalyzed 
ghrelin acylation.  The first set of tools I have constructed are several affinity-
tagged versions of human GOAT (hGOAT), which allows for expression and 
purification in Sf9 insect cells. The second is the development of a novel 
fluorescence-based assay (or test) for hGOAT activity.  This assay utilizes a 
fluorescently labeled peptide substrate that permits structure-reactivity analysis of 
hGOAT activity.  Using a series of synthetic fluorescent ghrelin mimics, we have 
been able to identify specific groups on ghrelin that potentially contribute to its 
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recognition by GOAT.  This data can be used in future studies to help elucidate 
the GOAT active site structure and design drugs to inhibit GOAT activity.  
 
GOAT Expression 
The lab chose to express hGOAT in S. frugiperda insect cells mainly due 
to the fact that there have been previous examples of this cell type being used for 
GOAT expression in the literature.
8
 My contribution to this project involved the 
separate engineering of three affinity tags onto the end of GOAT:  FLAG, Myc, 
and HA.  Each of these tags is a unique sequence of amino acids that can be 
selectively recognized by antibodies.  Antibody recognition is a key tool in 
protein expression studies, as it can be used to isolate the desired protein from all 
the other proteins made in the cell.  This would allow researchers in the Hougland 
lab to easily identify that GOAT has been expressed, something that has been 
difficult in the past. 
This project was carried out by taking artificial DNA that codes for the 
different Myc, HA, and FLAG protein tags and attaching them separately to the 
end of the DNA encoding hGOAT.  When this gene is expressed by the Sf9 cells, 
a GOAT-X protein conjugate (where X is either the Myc, FLAG, or HA) will be 
synthesized.  This conjugate can then be bound by antibodies designed to 
recognize the specific tags.  This project was successfully completed, with my 
synthesis of the GOAT-X DNA constructs being confirmed through gel 
electrophoresis and DNA sequencing. 
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Fluorescence Assay 
 While working on expressing GOAT, I also worked to develop a new 
assay to analyze GOAT reactivity.  The designed assay uses a shortened mimic of 
ghrelin with a fluorescent molecule called acrylodan attached to the end.  When 
the ghrelin mimic (called a substrate) is acylated by GOAT, a fatty acid chain is 
added to it.  This fatty acid makes the peptide less polar, which allows for 
separation from the unacylated substrate and also increases the fluorescence of the 
fluorescent tag.
10
 These changes in substrate properties upon acylation can be 
measured to determine how much ghrelin mimic has reacted, how quickly this 
reaction occurred, and properties of GOAT-catalyzed acylation.  
The first step in developing this assay was designing a synthetic scheme to 
create the fluorescent ghrelin mimic substrate.  The synthesis is done in one step, 
where the fluorescent acrylodan group is attached to a specific region of the 
ghrelin mimic. The new fluorescent substrate is then purified using Reverse Phase 
High Performance Liquid Chromatography (RP-HPLC), a technique that can 
separate different molecules based on their polarity.  The acrylodan group makes 
the substrate less polar than the unreacted ghrelin mimic, so the produced 
fluorescent ghrelin mimic can be easily separated and purified.  We also use a 
fluorescence detector during this process, which allows us to observe fluorescence 
emission as molecules pass through it.  This allows us to quickly determine when 
to purify our fluorescent substrate. 
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After successfully synthesizing the fluorescent substrate and expressing 
hGOAT, I was then able to test the validity of the assay by incubating the 
substrate with hGOAT and octanoyl-CoA and injecting the reaction on the HPLC.  
A new fluorescence peak not associated with any of the reactants was observed, 
later confirmed to be the acylated ghrelin mimic. Knowing that the assay worked, 
I was then able to move forward designing and carrying out experiments that 
tested GOAT’s substrate specificity and inhibition of activity by small molecules. 
I have been able to test GOAT substrate specificity by changing the amino 
acid sequence of the fluorescent ghrelin mimic so that it does not correspond with 
the natural sequence of ghrelin.  These substrates are reacted with GOAT and 
analyzed to see if GOAT would acylate a molecule with different molecular 
structure and characteristics than natural ghrelin.  These experiments indicate new 
natural amino acid sequences GOAT could recognize, which leads to the 
conclusion that there are other proteins in the body GOAT may modify.  In 
addition, my work sheds light on the kinds of molecular interactions that are 
occurring between GOAT and its substrates that allows for the acylation reaction 
to occur.   
GOAT inhibition is tested by incubating the traditional fluorescent ghrelin 
mimic with GOAT, octanoyl-CoA, and the compound being tested for inhibitive 
properties.  If the peak corresponding to the acylated substrate does not appear 
when the reaction mixture is injected on the HPLC, then the compound is 
indicated to be an inhibitor of GOAT.  This information is useful when 
considering the design of specific GOAT inhibitors for potential drug candidates.  
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Two metal chelators (molecules that bind metal ions) I have analyzed using this 
method have both successfully inhibited GOAT.  These results imply that a metal 
ion may be needed either for GOAT reactivity or to maintain GOAT structure. 
 
Conclusion 
 The experiments I have completed over the past two years in the Hougland 
lab lay the foundation for future studies of GOAT-catalyzed ghrelin acylation.  In 
addition to constructing protein conjugates of GOAT to assist in purification, I 
have also developed a novel fluorescent assay for GOAT activity. As well, I have 
successfully used this assay to determine characteristics of GOAT including 
substrate specificity as well as molecules that are capable of inhibiting it.  These 
results shed light on GOAT’s structure and catalytic mechanism, key information 
that is needed to design inhibitors that can decrease hunger and potentially cure 
life-threatening diseases such as obesity, diabetes, and Prader-Willi Syndrome, in 
the near future. 
